Riluzole-13C,15N2 structure
|
Common Name | Riluzole-13C,15N2 | ||
---|---|---|---|---|
CAS Number | 1215552-03-6 | Molecular Weight | 237.2253096 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C8H5F3N2OS | Melting Point | 113-116°C | |
MSDS | N/A | Flash Point | N/A |
Use of Riluzole-13C,15N2Riluzole-13C,15N2 is the 13C and 15N labeled Riluzole[1]. Riluzole is an anticonvulsant drug and belongs to the family of use-dependent Na+ channel blocker which can also inhibit GABA uptake with an IC50 of 43 μM[2][3]. |
Name | RILUZOLE-13C,15N2 |
---|
Description | Riluzole-13C,15N2 is the 13C and 15N labeled Riluzole[1]. Riluzole is an anticonvulsant drug and belongs to the family of use-dependent Na+ channel blocker which can also inhibit GABA uptake with an IC50 of 43 μM[2][3]. |
---|---|
Related Catalog | |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
References |
Melting Point | 113-116°C |
---|---|
Molecular Formula | C8H5F3N2OS |
Molecular Weight | 237.2253096 |
Storage condition | Refrigerator |